Letters Early trials of angiogenic factors have not targeted patients most at risk of ocular disease BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7210.643c (Published 04 September 1999) Cite this as: BMJ 1999;319:643 Article Related content Metrics Responses Peer review Related articles Clinical Review Therapeutic angiogenesis Published: 05 June 1999; BMJ 318 doi:10.1136/bmj.318.7197.1536
